Your search for supplemental oxygen returned 32 results

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air

Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives

Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

InflaRx is working to increase supply of the product in the US as quickly as possible.

Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo

The studies evaluated routine clinical practice data from more than 800 hospitals in the US.

Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.